EMN2025: The 6th edition of the International Conference on Multiple Myeloma will be held in Athens from 10 to 12 April 2025.
- The annual International Conference of the European Myeloma Network dedicated to research on multiple myeloma and blood neoplasms will be held in Athens from 10 al 12 April 2025.
- Three days of high-level scientific presentations and discussion sessions with international speakers from all over the world.
- Call For Abstracts open until 12 January 2025: a unique opportunity for young researchers under 40 years of age, with 8 travel grants to be awarded.
- Focus on new treatments, innovative clinical practices, and future prospects for the treatment of myeloma.
- Educational and “Meet the Experts” sessions, room for patient associations and in-depth analyses of clinical trials underway.
Next spring, from 10 to 12 April, Athens will host EMN2025, the sixth edition of the International Conference of the European Myeloma Network, the network of excellence at European level committed to research and study of treatments for blood neoplasms and multiple myeloma, organised by the network in collaboration with the ER Congressi agency.
Following the success of the 5th edition, which was held in Turin, Italy, in April 2024, the Greek capital is getting ready to become the hub of multiple myeloma research and education, offering haematologists, researchers and practitioners an extraordinary opportunity to learn about innovative treatments and the latest technological and scientific advances in this field.
Athens will host EMN2025, the sixth edition of the International Conference of the European Myeloma Network
EMN2024 – Turin (Italy), April 2024: Pieter Sonneveld – President EMN
The local organizers for EMN2025 are Professors Evangelos Terpos and Meletios Athanasios Dimopoulos from Athens, EMN members and key contributors to the network, who conceived the scientific programme together with the other scientific coordinators of the event, Pieter Sonneveld (EMN President), Mario Boccadoro (EMN Vice-President), Annemiek Broijl, Niels van de Donk, Maria Gavriatopoulou, Francesca Gay and Roberto Mina.
EMN2025 will be a meeting of great significance for all those engaged in the fight against multiple myeloma. Besides holding high-level scientific sessions, the conference promotes international collaboration and research sharing, and provides an opportunity for dialogue between haematologists, physicians, researchers, patient associations and industry leaders.
As in previous years, the Conference will devote special attention to young researchers under 40: they will have an opportunity to submit their abstracts to a panel of experts from all over Europe, who will evaluate them and will award to the best 8 a travel grant covering the expenses to attend the event. The Call For Abstracts is already posted on the official website emn2025.com and will remain open for submission until 12 January 2025: a unique opportunity to present one’s work at the Conference, exchange views and get valuable feedback from professionals in this field.
The scientific programme includes:
- EBAH accredited live educational sessions on current developments in myeloma research and clinical practices.
- Topical issues of great clinical relevance, including treatment approaches for patients with high-risk smouldering multiple myeloma, the role of MRD, new diagnosis and treatment selection techniques, and a new definition of high risk.
- New joint EHA and EMN guidelines, essential in clinical practice.
- “Meet the Experts” sessions: small interactive discussion groups with experts in specific topics.
- A session dedicated to patients’ associations, to include their views into future research and treatments.
- Sponsored symposia, readings, presentations of abstracts and posters, oral presentations.
EMN2024 – Turin (Italy), April 2024EMN2025 will focus in particular on clinical trials underway and their possible impact on clinical practice, as well as on major advances in the use of Artificial Intelligence, new prognostic factors for a better characterisation of therapy selection, and the development of treatments increasingly targeted to the needs of individual patients.
EMN2024 – Turin (Italy), April 2024: Mario Boccadoro Vice-President EMN
Registration for the conference will open on 23 January 2025, with Early Bird benefits available until 4 April. To submit abstracts, register or view the full programme, soon to be made available, please visit the EMN’s official website emn2025.com.
The website will also include an option for the accreditation of media interested in attending the conference.
19 December 2024
Anicecommunication, EMN media relations and PR agency >
